IL229947B - A bacterial host strain expressing recombinant dsbc - Google Patents

A bacterial host strain expressing recombinant dsbc

Info

Publication number
IL229947B
IL229947B IL22994713A IL22994713A IL229947B IL 229947 B IL229947 B IL 229947B IL 22994713 A IL22994713 A IL 22994713A IL 22994713 A IL22994713 A IL 22994713A IL 229947 B IL229947 B IL 229947B
Authority
IL
Israel
Prior art keywords
bacterial host
host strain
expressing recombinant
strain expressing
recombinant dsbc
Prior art date
Application number
IL22994713A
Other languages
English (en)
Hebrew (he)
Original Assignee
Ucb Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa
Publication of IL229947B publication Critical patent/IL229947B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL22994713A 2011-07-13 2013-12-17 A bacterial host strain expressing recombinant dsbc IL229947B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11173880 2011-07-13
PCT/EP2012/002945 WO2013007388A1 (en) 2011-07-13 2012-07-13 Bacterial host strain expressing recombinant dsbc

Publications (1)

Publication Number Publication Date
IL229947B true IL229947B (en) 2019-10-31

Family

ID=46545736

Family Applications (1)

Application Number Title Priority Date Filing Date
IL22994713A IL229947B (en) 2011-07-13 2013-12-17 A bacterial host strain expressing recombinant dsbc

Country Status (27)

Country Link
US (2) US9725516B2 (enExample)
EP (2) EP2731973B1 (enExample)
JP (3) JP6431370B2 (enExample)
KR (1) KR102023786B1 (enExample)
CN (1) CN103649124B (enExample)
AU (1) AU2012283388B2 (enExample)
BR (1) BR112013032871B1 (enExample)
CA (1) CA2841824C (enExample)
CY (1) CY1119985T1 (enExample)
DK (1) DK2731973T3 (enExample)
EA (1) EA031449B1 (enExample)
ES (1) ES2659155T3 (enExample)
HR (1) HRP20180226T1 (enExample)
HU (1) HUE035674T2 (enExample)
IL (1) IL229947B (enExample)
IN (1) IN2014DN00202A (enExample)
LT (1) LT2731973T (enExample)
ME (1) ME02957B (enExample)
MX (1) MX348738B (enExample)
NO (1) NO2731973T3 (enExample)
PL (1) PL2731973T3 (enExample)
PT (1) PT2731973T (enExample)
RS (1) RS56926B1 (enExample)
SG (1) SG10201807560XA (enExample)
SI (1) SI2731973T1 (enExample)
SM (1) SMT201800068T1 (enExample)
WO (1) WO2013007388A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2125894T3 (pl) * 2007-03-22 2019-08-30 Biogen Ma Inc. Białka wiążące, w tym przeciwciała, pochodne przeciwciał i fragmenty przeciwciał, które swoiście wiążą się z CD154 i ich zastosowania
EP2480661A1 (en) 2009-09-24 2012-08-01 UCB Pharma, S.A. Bacterial host strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
MX348738B (es) 2011-07-13 2017-06-27 Ucb Pharma Sa Cepa huesped bacteriana que expresa dsbc recombinante.
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
GB201223276D0 (en) * 2012-12-21 2013-02-06 Ucb Pharma Sa Antibodies and methods of producing same
US10358460B2 (en) 2014-12-22 2019-07-23 Ucb Biopharma Sprl Protein manufacture
KR101810778B1 (ko) * 2015-06-23 2017-12-20 서울대학교산학협력단 Cd154 결합 폴리펩타이드 및 그 용도
JP6991978B2 (ja) 2016-01-27 2022-02-03 メディミューン,エルエルシー 定められるグリコシル化パターンを有する抗体を調製するための方法
US11453883B2 (en) 2018-04-05 2022-09-27 Bio-Rad Abd Serotec Gmbh Display systems for proteins of interest
KR20210090645A (ko) * 2018-11-05 2021-07-20 제넨테크, 인크. 원핵 숙주 세포에서 2개의 사슬 단백질을 생산하는 방법
CN109371049A (zh) * 2018-11-14 2019-02-22 天津大学 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用
EP3942079A1 (en) 2019-03-18 2022-01-26 Bio-Rad ABD Serotec GmbH Protection of spytag-containing periplasmic fusion proteins from protease tsp and ompt degradation
US20240327849A1 (en) * 2019-08-05 2024-10-03 Wacker Chemie Ag Bacterial strain for releasing a recombinant protein in a fermentation method

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8907617D0 (en) 1989-04-05 1989-05-17 Celltech Ltd Drug delivery system
US5508192A (en) 1990-11-09 1996-04-16 Board Of Regents, The University Of Texas System Bacterial host strains for producing proteolytically sensitive polypeptides
US5264365A (en) 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
GB9112536D0 (en) 1991-06-11 1991-07-31 Celltech Ltd Chemical compounds
US5474771A (en) 1991-11-15 1995-12-12 The Trustees Of Columbia University In The City Of New York Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
EP0640093A4 (en) 1992-04-28 1996-06-05 Univ Michigan HUMAN CRABP-I AND CRABP-II.
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5304472A (en) 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
AU2660397A (en) 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
GB9625640D0 (en) 1996-12-10 1997-01-29 Celltech Therapeutics Ltd Biological products
US6083715A (en) 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
JP2000083670A (ja) 1998-09-09 2000-03-28 Hsp Kenkyusho:Kk DsbA/DsbB/DsbC/DsbD発現プラスミド
CA2377491C (en) 1999-06-29 2008-01-29 Siga Technologies, Inc. Assay for degp protease inhibitors
GB0006398D0 (en) 2000-03-16 2000-05-03 Novartis Ag Organic compounds
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
AU2001287040A1 (en) 2000-09-01 2002-03-13 Biogen, Inc. Methods of designing and producing novel compounds having improved binding affinity for cd154 or other trimeric proteins
AU8867501A (en) 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
DE60135498D1 (de) * 2000-12-14 2008-10-02 Genentech Inc Produktion von ganzen Antikörpern in prokaryontischen Zellen
RU2287574C2 (ru) 2000-12-14 2006-11-20 Дженентек, Инк. БАКТЕРИЯ Е.coli, ПРОДУЦИРУЮЩАЯ ГЕТЕРОЛОГИЧНЫЙ ПОЛИПЕПТИД, И СПОСОБ ПРОДУЦИРОВАНИЯ ПОЛИПЕПТИДА
TWI334439B (en) 2001-08-01 2010-12-11 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
JP4461210B2 (ja) 2001-08-27 2010-05-12 ジェネンテック, インコーポレイテッド 抗体発現系とその構築法
GB0124317D0 (en) 2001-10-10 2001-11-28 Celltech R&D Ltd Biological products
EP2022799A2 (en) 2001-11-16 2009-02-11 Biogen Idec Inc. Polycistronic expression of antibodies
GB0129105D0 (en) * 2001-12-05 2002-01-23 Celltech R&D Ltd Expression control using variable intergenic sequences
DK1517921T3 (da) 2002-06-28 2006-10-09 Domantis Ltd Immunglobulin-enkeltvariable antigen-bindende domæner og dobbeltspecifikke konstruktioner deraf
NZ538996A (en) 2002-10-31 2008-04-30 Genentech Inc Methods and compositions for increasing antibody production
EP1570267B1 (en) 2002-12-03 2011-10-12 UCB Pharma, S.A. Assay for identifying antibody producing cells
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
JP4667383B2 (ja) 2003-06-13 2011-04-13 バイオジェン・アイデック・エムエイ・インコーポレイテッド アグリコシル抗cd154(cd40リガンド)抗体およびその使用
DK1639011T3 (da) 2003-06-30 2009-02-16 Domantis Ltd Pegylerede enkelt-domæne antistoffer (dAb)
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
CN1894695A (zh) 2003-07-26 2007-01-10 比奥根艾迪克Ma公司 具有改良的抗原结合亲和力的改变的抗体
EA014226B1 (ru) 2004-07-26 2010-10-29 Байоджен Айдек Ма Инк. Антитела к cd154, их фрагменты и способы применения антител и фрагментов
CA2577082A1 (en) * 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
GB0520169D0 (en) 2005-10-04 2005-11-09 Celltech R&D Ltd Biological products
PL2125894T3 (pl) * 2007-03-22 2019-08-30 Biogen Ma Inc. Białka wiążące, w tym przeciwciała, pochodne przeciwciał i fragmenty przeciwciał, które swoiście wiążą się z CD154 i ich zastosowania
ES2667729T3 (es) 2007-09-26 2018-05-14 Ucb Biopharma Sprl Fusiones de anticuerpos con doble especificidad
US7662587B1 (en) 2009-03-05 2010-02-16 E. I. Du Pont De Nemours And Company Gene knockout mutations that increase peptide production
EP2480661A1 (en) 2009-09-24 2012-08-01 UCB Pharma, S.A. Bacterial host strain
US8470552B2 (en) 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
TWI600760B (zh) * 2009-11-05 2017-10-01 建南德克公司 分泌異源多肽之方法及組合物
GB201000588D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000590D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
MX348738B (es) * 2011-07-13 2017-06-27 Ucb Pharma Sa Cepa huesped bacteriana que expresa dsbc recombinante.
EP2546267A1 (en) 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product

Also Published As

Publication number Publication date
EP2731973B1 (en) 2017-11-15
JP6431370B2 (ja) 2018-11-28
PL2731973T3 (pl) 2018-04-30
CY1119985T1 (el) 2018-12-12
MX348738B (es) 2017-06-27
DK2731973T3 (da) 2018-01-29
SI2731973T1 (en) 2018-04-30
KR102023786B1 (ko) 2019-09-20
RS56926B1 (sr) 2018-05-31
US9957328B2 (en) 2018-05-01
HK1194393A1 (zh) 2014-10-17
JP2018019719A (ja) 2018-02-08
IN2014DN00202A (enExample) 2015-06-05
EA201490274A1 (ru) 2014-05-30
US20170335003A1 (en) 2017-11-23
ES2659155T3 (es) 2018-03-14
PT2731973T (pt) 2018-02-22
BR112013032871A2 (pt) 2017-01-24
HUE035674T2 (en) 2018-05-28
EP2731973A1 (en) 2014-05-21
EP3339325A1 (en) 2018-06-27
AU2012283388B2 (en) 2017-04-20
CN103649124A (zh) 2014-03-19
SMT201800068T1 (it) 2018-03-08
EA031449B1 (ru) 2019-01-31
ME02957B (me) 2018-07-20
NO2731973T3 (enExample) 2018-04-14
CA2841824C (en) 2021-07-13
LT2731973T (lt) 2018-02-26
BR112013032871A8 (pt) 2022-08-23
WO2013007388A1 (en) 2013-01-17
JP7062626B2 (ja) 2022-05-17
SG10201807560XA (en) 2018-10-30
JP2020028299A (ja) 2020-02-27
JP2014521313A (ja) 2014-08-28
HRP20180226T1 (hr) 2018-03-09
BR112013032871B1 (pt) 2022-09-27
AU2012283388A1 (en) 2014-01-09
US20140141468A1 (en) 2014-05-22
CN103649124B (zh) 2016-04-13
MX2014000302A (es) 2014-02-17
CA2841824A1 (en) 2013-01-17
US9725516B2 (en) 2017-08-08
KR20140039240A (ko) 2014-04-01

Similar Documents

Publication Publication Date Title
IL229947B (en) A bacterial host strain expressing recombinant dsbc
ZA201300147B (en) Recombinant host cells comprising phosphoketolases
PT2523969T (pt) Estirpe bacteriana hospedeira que expressa dsbc recombinante e tem atividade de tsp reduzida
IL235041B (en) Recombinant bacterial host cell for protein expression
SG10201606462WA (en) Bacterial host strain
PL2714888T3 (pl) Rekombinowane drożdże
GB201409238D0 (en) Lossless embedded additional data
ZA201308946B (en) Recombinant yeast expressing agt1
GB2496423B (en) Data compression
AU2011100109A4 (en) Space Saver Spacer
GB201000606D0 (en) Bacterial host strain
GB201000589D0 (en) Bacterial host strain
GB201000605D0 (en) Bacterial host strain
GB0916821D0 (en) Bacterial host strain
GB0916817D0 (en) Bacterial host strain
GB0916822D0 (en) Bacterial host strain
GB0916818D0 (en) Bacterial host strain
AU2011900690A0 (en) Stress responsive expression
AU2011905010A0 (en) Reciept Card
GB201016641D0 (en) Recombinant trypanosome
AU2011902779A0 (en) Barbeque control system
AU2011904323A0 (en) Photobioreactor
AU2011901401A0 (en) Improved Mechanical Products
AU2011903073A0 (en) Mattress construction
AU2011903088A0 (en) Umbilical Cord Tie

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed